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RNA interference (RNAi) is the process by which double-stranded RNA (dsRNA) directs sequence-specific degradation of messenger
RNA in animal and plant cells. In mammalian cells, RNAi can be triggered by 21–23 nucleotide duplexes of small interfering RNA (siRNA).
Strategies to inhibit RNA virus multiplication based on the use of siRNAs have to consider the high genetic polymorphism exhibited by this
group of virus. Here we described a significant cross-inhibition of foot-and-mouth disease (FMD) virus (FMDV) replication in BHK-21 cells
by siRNAs targeted to various conserved regions (5VNCR, VP4, VPg, POL, and 3VNCR) of the viral genome. The results showed that siRNAs
generated in vitro by human recombinant dicer enzyme gave an inhibition of 10- to 1000-fold in virus yield of both homologous (HKN/2002)
and heterologous (CHA/99) isolates of FMDV serotype O at 48 h post-infection (hpi). The inhibition extended to at least 6 days post-
infection. For serotype Asia1, the virus yield in YNBS/58-infected cells examined at 12, 24, and 48 hpi decreased by ~10-fold in cells
pretreated with HKN/2002-specific siRNAs, but there was no significant decrease at 60 hpi. The inhibition was specific to FMDV replication,
as no reduction was observed in virus yield of pseudorabies virus, an unrelated virus. Moreover, we also demonstrated an enhanced viral
suppression could be achieved in BHK-21 cells with siRNA transfection after an infection had been established. These results suggested that
siRNAs directed to several conserved regions of the FMDV genome could inhibit FMDV replication in a cross-resistance manner, providing
a strategy candidate to treat high genetic variability of FMDV.
D 2005 Elsevier Inc. All rights reserved.
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RNA interference is an ancient natural antiviral mech-
anism that directs silencing of gene expression in a
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1 These authors contributed equally to this work.invaluable research tool, allowing much more rapid
characterization of the function of known genes. But can
RNA interference be used as an effective antiviral strategy
in mammalian cells? Recently, in tissue culture models,
impressive results have been achieved against various
cancer cells by using RNA interference to target oncogenes
and against human immunodeficiency virus (HIV), influ-
enza, and polioviruses by targeting viral genes (Coburn and
Cullen, 2002; Damm-Welk et al., 2003; Ge et al., 2003;
Gitlin et al., 2002). These findings raise our interests of005) 51–59
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mouth disease (FMD) virus (FMDV). Our previous study
demonstrated that a DNA vector-based RNAi technology
could specifically suppress the expression of FMDV VP1 in
BHK-21 cells and inhibit FMDV replication in BHK-21
cells and suckling mice (Chen et al., 2004). Present data
have generated much more hope for the use of RNAi as a
novel antiviral therapy.
FMDV has the potential to cause explosive epidemics of
FMD because of its diverse host range, low infectious dose
requirement, high quantity of virus excretion, multiple routes
of transmission, and short incubation period. The measures
of control are routine vaccination and slaughter policy. As
for routine vaccination, protective response usually occurs at
15 days after immunization. However, the speed of spread of
FMDV is so rapid that pigs infected can release as much
aerosol virus in a 24-h period as 3000 cattle. For slaughter
policy, if an outbreak threatened to become extensive, it is
considered that this strategy alone might not be sufficient to
eradicate the virus. These situations demonstrate the
importance of having a rapidly assimilated bemergencyQ
vaccine capable of inducing early protection. The most
important properties of an emergency FMD vaccine are the
early induction of protective immunity and broad spectrum
activity (Salt et al., 1998). Although the rapid induction of
protection against aerosol infection within 4 days of
vaccination has been an intensive area of study in cattle
(Doel et al., 1994), sheep (Cox et al., 1999), and pigs (Salt et
al., 1998), RNAi technology might have demonstrated more
rapid speed of suppressing virus spread and more broader
suppression spectrum by targeted to conserved regions of
FMDV genome.
Like other RNA viruses, FMDV has high variability.
Seven distinct serotypes and more than 60 subtypes of the
virus have been characterized by serological analysis.
FMDV is able to escape the host immune system by high
variability of its surface antigens. Thus, establishing RNAi
as a viable approach against FMDV requires resolving at
least one major issue (Gitlin and Andino, 2003): the high
genetic variability of viruses or viral escape, because
viruses are likely to evade any given siRNA by mutations
of the target sequences. Therefore, it may be important to
produce multiple siRNAs, focusing on the conserved region
of the viral genome or to use combinations of siRNAs
(Gitlin and Andino, 2003; Gitlin et al., 2002; Song et al.,
2003).
In this study, we describe a cross-inhibition of FMDV
replication in BHK-21 cells by siRNAs targeted to various
conserved regions of the FMDV genome. The multiple
siRNAs have been used to target several viral genes that are
essential for virus replication, including a long 5V no-coding
region (5VNCR), a shorter 3V no-coding region (3VNCR), a
small covalently bound virus-encoded protein (VPg), a viral
polymerase (POL), and a viral capside protein (VP4). We
further examine the possibility that the presence of intra-
cellular target mRNA could sustain RNA silencing.Results
siRNAs effectively suppressed the expression of fusion green
fluorescent protein in BHK-21 cells
The siRNAs targeted to the conserved regions of FMDV
genome were generated in vitro by human recombinant
Dicer enzyme, as described in Fig. 1. To identify an
effective inhibitory effect of siRNAs, the cDNA cassettes of
these regions were inserted into the 5V end of enhanced
green fluorescent protein (EGFP) gene to construct reporter
plasmids (Fig. 2). The reporter plasmids were cotransfected
into BHK-21 cells with either the homologous siRNAs or
the heterologous siRNAs. Results showed that the fre-
quency of EGFP-expressing cell was markedly reduced in
cells transfected with homologous siRNAs relative to cells
transfected with heterologous siRNAs or non-transfected
cells (Fig. 3A). Fluorescence-activated cell sorting demon-
strated that the levels of inhibition mediated by the siRNAs
were similar among the different experiment groups and
significantly higher than the control group (cotransfection
with heterologous siRNAs or without siRNAs) (Fig. 3B). To
further demonstrate the levels of inhibition, cells were
collected at 24 h post-transfection and real-time quantitative
RT-PCR (Q-RT-PCR) analysis was performed. The level of
target RNAs, as determined by RT-PCR, was also signifi-
cantly reduced in cells transfected with homologous siRNAs
(Fig. 3C). Melt-curve analysis confirmed the specific
amplification of RT-PCR products (data not shown). Data
of the real-time Q-RT-PCR were markedly reproducible
based on the cycle threshold (CT) values derived from two
separate experiments (Table 1). The results suggested that
the siRNA generated by in vitro transcription could
effectively and specifically inhibit the expression of FMDV
conserved regions in BHK-21 cells.
Inhibition of FMDV replication in BHK-21 cells by siRNAs
To examine the suppression effect of siRNAs on the
replication of virus, cells in one well of 96-well plates were
transfected with 0.1 Ag siRNAs. After 5 h, cells were
infected with 100 50% tissue culture infective doses
(TCID50) of HKN/2002 (FMDV serotype O). Cells were
observed continuously under the microscope. The results
showed that cells transfected with siRNAs significantly
reduced susceptibility to FMDV infection, relative to cells in
the control groups (mock-transfection or infected with an
unrelated pseudorabies virus (PRV) Ea). The effect of RNAi
on viral replication was further investigated by measuring
the TCID50 of cells—lysed supernatant taken at 48 h and
96 h after viral challenge. Consistent with this observation,
supernatant TCID50 of FMDV was reduced by 50- to 100-
fold (Fig. 4A), in comparison with the control group. Thus,
siRNAs targeted to the conserved regions of FMDV genome
were effective and specific, and resulted in an overall
reduction of virus load. The ability of siRNA-transfected
Fig. 1. Schematic representations of target viral mRNA and generation of siRNAs. (A) The FMDV genome contains a unique open reading frame. The filled
boxes show the regions along viral genome targeted by FMDV-specific siRNAs. (B) The siRNAs are produced from in vitro transcription by T7 RNA
polymerase and cleavage by recombinant Dicer enzyme. (C) The dsRNAs generated from in vitro strategy and the corresponding siRNAs were separated on a
2.5% agarose gel and visualized under UV light.
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(data not shown).
To further test whether the siRNAs targeted to the
conserved regions of FMDV genome could inhibit the
replication of heterologous FMDV isolate, the CHA/99
strain of FMDV serotype O and the YNBS/58 strain of
FMDV serotype Asia1 were employed to perform viral
challenge. As described above, transfected cells (at 5-h post-
transfection) were infected with 100 TCID50 of CHA/99 or
YNBS/58. A transient inhibition of virus yield was observed
in cells transfected with FMDV-interfering siRNAs. The
viral titer in CHA/99-infected cells was reduced by 15- to
1000-fold at 48 hpi (Fig. 4B). The antiviral effect extended
to at least 6 days, as had been shown in cells infected by
HKN/2002. Virus yield, in YNBS/58-infected cells exam-
ined at 12, 24, and 48 hpi, decreased by ~10-fold in cells
pretreated with 5VNCR, POL, or 3VNCR siRNAs (Fig. 4C),
but there was no significant decrease at 60 hpi. As expected,
HKN/2002-specific VP4 and VPg siRNAs gave no marked
inhibition to YNBS/58 at most of time points assayed. Mock
transfection or cells infected with PRV did not show a
significant reduction in virus yield (Fig. 4D). When cells
were observed under the light-field microscope, the effect ofsiRNAs protecting cells from lysis was consistent with the
reduction in virus yield (data not shown). These data
indicated that transfection with siRNAs corresponding to
conserved regions of FMDV genome not only conferred a
clear reduction in homologous FMDV progeny, but also
permitted the induction of cross-resistance to heterologous
FMDV infection.
Enhanced RNAi effect by siRNA transfection after an
established infection
Our previous study showed that RNAi effect could be
enhanced by co-administration of the VP1 expression
plasmid with siRNA into suckling mice before viral
challenge. To further examine the hypothesis that RNAi
effect may be long lasting if the target mRNA is continually
available and to test if siRNAs can stably suppress FMDV in
previously infected cells, BHK-21 cells were infected with
100 TCID50 of FMDV before siRNA transfection. After 1 h,
transfection was followed. Cells were observed continu-
ously under the bright-field microscope at 24 h after
transfection and supernatant of cells, used to measure viral
titer, was collected at 48 h after infection. Except 3VNCR
Fig. 2. Reporter plasmid construction. The cDNA cassettes corresponding
to the conserved regions of the FMDV genome were cloned into the
pEGFP-N1 vector. PCMV = human cytomegalovirus (CMV) immediate
early promoter; PSV40 = SV40 early promoter; EGFP = enhanced green
fluorescent protein gene; Kanr/Neor = kanamycin/neomycin resistance
gene; SV40 poly A = SV40 early mRNA polyadenylation signal; HSV TK
poly A = herpes simplex virus (HSV) thymidine kinase (TK) polyadeny-
lation signal; SV40 ori = SV40 origin of replication; pUC ori = pUC
plasmid replication origin.
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to inhibit viral replication with a higher reduction in virus
titer than that in pre-transfected cells (Student’s t test, P b
0.0005 or P b 0.01) (Fig. 5A). Moreover, siRNAs
effectively suppressed viral replication for prolonged
periods in previously infected cells. The effects of suppres-
sion on virus replication were similar at 120 hpi by
examining the cytopathic effect (CPE) under the micro-
scope. However, FMDV suppression mediated by siRNA
pre-transfection was progressively impaired and lost by 150
hpi. In contrast, viral inhibition by siRNAs in pre-infected
cells was sustained for at least 198 hpi (Fig. 5B). This
observation indicated that long-lasting and enhanced viral
suppression could be achieved with siRNA in BHK-21 cells
with an established infection, in agreement with previous
studies (Song et al., 2003).Discussion
Previously, we have investigated in vitro the inhibitory
effect of VP1-specific siRNA on FMDV replication in
BHK-21 cells (Chen et al., 2004). The results showed that
BHK-21 cells transiently transfected with siRNA-express-
ing plasmids were specifically resistant to FMDV infection
when exposed to 100 TCID50 of virus with homologous
VP1 sequence. However, the VP1-specific 21-nt siRNA
with 2 mismatches over the heterologous virus did notconfer significant inhibitory effect to viral replication of the
heterologous virus. In this study, we demonstrated that
siRNAs directed to the conserved regions of FMDV
genome, namely 5VNCR, VP4, VPg, POL, and 3VNCR,
could inhibit the replication of both FMDV strains serotype
O (the homologous HKN/2002 and the heterologous CHA/
99). Furthermore, the replication of FMDV serotype Asia1
(YNBS/58) could also be altered in cells transfected with
some of HKN/2002-specific siRNAs. Our data suggest that
it is feasible to produce multiple siRNAs, focusing on the
conserved regions of the viral genome, against the high
genetic variability of RNA viruses or the viral escape.
Five genes, 5VNCR, VP4, VPg, POL, and 3VNCR, were
chosen as targets in this study for two reasons. Firstly, it is
well known that different siRNAs induce different levels of
RNAi activity (Hohjoh, 2002; Holen et al., 2002). There-
fore, in order to realize efficient RNAi induction in
mammalian cells, it would have been important to screen
appropriate target regions along the FMDV genome con-
ferring a strong RNAi activity. Secondly, because of the
high genetic variability of FMDV, the relatively conserved
regions with important functions were focused on. The
3VNCR is essential for FMDV replication in cell culture
(Sa´iz et al., 2001), and the evidence available for other
picornaviruses indicates that 3VNCR is involved in the
interaction with cellular and/or viral proteins during RNA
replication (Mellits et al., 1998; Todd and Semler, 1996;
Todd et al., 1995). The 5VNCR is predicted to form extensive
secondary structures relative to translation initiation (Pili-
penko et al., 1989). Because of the importance of 5VNCR
and 3VNCR to FMDV infection, current development of
anti-FMDV strategy has focused on the inhibition of viral
infection by combinations of RNA transcripts correspond-
ing to the 5V and 3VNCR (Bigeriego et al., 1999). The RNA-
dependent RNA polymerase (RdRp) 3Dpol and VPg of
FMDV represent another two targets for the development of
antiviral reagent since the initiation of picornaviral RNA
replication is regulated predominantly by the interaction
between 3Dpol, VPg, an RNA template, and other viral and
cellular cofactors (Barton et al., 1995; Lama et al., 1994;
Paul et al., 1998). 3Dpol is a key enzyme in viral RNA
replication (Chen et al., 2003; O’Reilly and Kao, 1998;
Steitz, 1998;). VPg has been shown to be essential for
protein-primed initiation of both the positive and negative
RNA strand replication (Cheney et al., 2003; Wimmer,
1982). VP4 is only one structural protein, located inside the
mature virus particle, and involved in conversion of
provirions to mature virions (Bachrach, 1968).
In this study, the efficiency of gene silencing varied
between siRNAs targeted to different region of genome, and
also varied between FMDV serotypes. The phenomenon is
consistent with other investigations (Bohula et al., 2003;
Harborth et al., 2001; Vickers et al., 2003). At present, there
is still a lack of clear understanding on the mechanisms that
determine the gene-silencing efficiency of a given siRNA. A
number of hypotheses have been proposed in the literature,
Fig. 3. Effect of RNAi on the expression of FMDV conserved region in BHK-21 cells. (A) Fluorescence micrographs of cells transfected with reporter plasmids
and cotransfected with either the corresponding or non-corresponding siRNA with Lipofectamine 2000 regent (Invitrogen). At 24 h after transfection,
representative fields were photographed. (B) Cells were analyzed for EGFP expression by fluorescence-activated cell sorting and the level of fluorescence
relative to the control was quantitated. Data are the averages F standard deviations from three separate experiments. (C) Real-time Q-RT-PCR analysis for
expression of FMDV-conserved regions. One amplification plot of two separate real-time Q-RT-PCR (Table 1) of samples is shown here. The y-axis represents
the PCR baseline subtracted relative fluorescence units (RFU). Cycle number is displayed on the x-axis.
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the positional effect (Holen et al., 2002); (b) the local
structure of the targeted mRNA may affect the accessibility
of the siRNA (Bohula et al., 2003; Kretschmer-Kazemi FarTable 1
Reproducibility of real-time Q-RT-PCR
Groups Cycle threshold (CT)
range
CT (mean)
p5NCR-EGFP 9.13 – 10.08 9.61
pVP4-EGFP 8.27 – 9.11 8.69
pVPg-EGFP 10.21 – 9.59 9.90
pPOL-EGFP 9.98 – 10.74 10.36
p3NCR-EGFP 8.92 – 10.43 9.68
p5NCR-EGFP + 5VNCR siRNA 13.56 – 14.62 14.09
pVP4-EGFP + VP4 siRNA 13.39 – 14.38 13.89
pVPg-EGFP + VPg siRNA 13.88 – 14.12 14.00
pPOL-EGFP + POL siRNA 13.48 – 14.43 13.96
p3NCR-EGFP + 3VNCR siRNA 15.65 – 15.20 15.43
p5NCR-EGFP + VP4 siRNA 9.06 – 9.43 9.25
pVP4-EGFP + VPg siRNA 8.57 – 9.18 8.88
pVPg-EGFP + POL siRNA 9.57 – 9.31 9.44
pPOL-EGFP + 3VNCR siRNA 11.11 – 11.14 11.13
p3NCR-EGFP + 5VNCR siRNA 9.54 – 10.32 9.93and Sczakiel, 2003; Luo and Chang, 2004; Vickers et al.,
2003); (c) factors such as sequence-dependent mRNA pro-
duct release or differential efficiency of 5V siRNA phospho-
rylation may influence the efficiency of the siRNA (Nykanen
et al., 2001). Recent studies show that the gene-silencing
efficiency of siRNA is strongly dependent on the local
structure of mRNA at the targeted region. To further test the
relationship between silencing efficiency and targeted
mRNA, further work needs to be done. Additionally, in our
study, the inhibition induced by siRNAs against the HKN/
2002 sequences seems apparently somewhat greater against
the heterologous isolate CHA/99 than the homologous virus
for at least the 5VNCR target at 96 hpi (Fig. 4). 3VNCR siRNAs
elicited more effective inhibitory response to HKN/2002 than
to CHA/99, as expected previously. Besides the interfering
factors described above as explanations, a relatively higher
level of sequence similarity at the nucleotides for 5VNCR,
VP4, VPg, and POL than that for 3VNCR might partially
account for the unusual silencing efficiency against heterol-
ogous virus. Moreover, we could not rule out the possibility
that the agreeable mismatches within siRNA duplexes
enhance RNAi activity over the severe matches within
Fig. 4. Decrease of virus yield in BHK-21 cells transfected with FMDV-specific siRNAs. Cells were challenged with (A) FMDV HKN/2002, (B) FMDV CHA/
99, and (C) FMDV YNBS/58 at 5 h post-transfection. Culture supernatants were collected at several time points assayed after FMDV challenge, and virus
yields were measured by TCID50. (D) As a control, an unrelated virus, PRV was used to examine the specific suppression activity of siRNA.
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(Hohjoh, 2004; Yu et al., 2002).
In agreement with the previous study (Song et al., 2003),
our work also demonstrates an enhancement of RNAi effect
on the replication of FMDV in BHK-21 cells after an
infection has been established. However, it is not clear why
siRNAs targeted to 3VNCR do not present an enhanced
effect in this experiment. The possible reason is the severe
specificity of 3VNCR mRNA in structure. Previous inves-
tigators have suggested that the presence of target mRNA
may sustain siRNA (Platerk, 2002; Tuschl, 2002). We
would like to attribute this promoted antiviral activity to the
presence of a rudimentary form of immune memory (Gitlin
and Andino, 2003). An alternative explanation is that the
RNAi machinery could be naturally triggered in virally
infected cells (Ding et al., 2004). When specific siRNAs
generated in vitro are introduced into these cells, antiviral
response based on RNAi will be faster, effective, and long-
lasting. Additional experiments are clearly needed to
explain this observation.
Our results take RNAi-based antiviral strategy a step
forward to the control of FMD. Other than viral escape,
several critical issues need to be addressed to improve RNAi
effectiveness as an antiviral strategy against RNA viruses
particularly in animal model systems and naturally suscep-tible animals, including persistence and enhancement of
RNA silencing effect, siRNA delivery, systemic effect, etc.
Researchers would have been expected to convert more and
more new laboratory approaches based on RNAi to effective
procedures to treat viral diseases.Materials and methods
Cell culture and viruses
Baby hamster kidney cells 21 (BHK-21) were cultured in
RPMI 1640 medium supplemented with 10% (v/v) FBS,
10 mM HEPES, 2 mM glutamine, 1 mM sodium pyruvate,
100 Uml1 penicillin, and 100 Agml1 streptomycin
(Invitrogen). FMDV types O (HKN/2002 [GenBank acces-
sion number AF525458] and CHA/99 [unpublished]),
FMDV types Asia1 (YNBS/58 [GenBank accession number
AY390432]), and one PRV isolate (Ea [GenBank accession
number AY318876]) were used for viral challenge.
Selection of target sequences
The reference sequences of the conserved regions of
FMDV genome were obtained from the National Center for
Fig. 5. The promoted antiviral effect by transfection with siRNAs after an infection has been established. (A) Cells were infected with FMDV HKN/2002 for 1
h prior to transfection with siRNAs. As a control, cells were transfected with siRNAs for 5 h prior to virus infection. Culture supernatants were collected at 48
hpi and the virus yields of two different treatments were measured. Error bars indicate standard deviations. Statistical analyses were carried out by Student’s t
test, indicating statistically significant difference ( P b 0.0005 or P b 0.01) between the two different treatments and against the data of the control. (B) The
promoted antiviral effects had been demonstrated till 198 hpi. Cells were visualized with an Olympus BH-2 microscope, and representative bright-field images
were photographed. The cells on the upper panel were photographed at 150 hpi. The cells on the lower panel were photographed at 198 hpi.
M. Liu et al. / Virology 336 (2005) 51–59 57Biotechnology Information (NCBI) website (www.ncbi.
nlm.nih.gov) and compared with those of HKN/2002 by
nucleotide (nt) BLAST. The genes and the regions of interest
were essential during the life cycle of the virus and relatively
conserved at the nucleotide sequences, as diagrammed in
Fig. 1A. The region in 5VNCR contains the sequence
corresponding to nt 500–648 of the genome of HKN/2002.
The regions in VP4, VPg, POL, and 3VNCR contain the
sequences corresponding to nt 1652–1821, 5798–5934,
7694–7878, and 8012–8102 of the genome of HKN/2002,
respectively. These regions share significant sequence
similarity at the nucleotides, ranging from 85% to 98% for
serotype O, A, C, and Asia 1. Especially, the sequencesimilarity ranges from 91% to 98% between the serotype O
HKN/2002 and CHA/99, namely, 95%, 94%, 97%, 98%, and
91% for 5VNCR, VP4, VPg, POL, and 3VNCR, respectively.
For the serotype O HKN/2002 and serotype Asia1 YNBS/
58, the regions in 5VNCR, POL, and 3VNCR show similarities
of 93%, 97%, and 91%, respectively, but those in VP4 and
VPg show no significant sequence similarity.
Preparations of siRNAs
The siRNAs were produced from in vitro transcripts
according to the Dicer siRNA Generation Kit (Catalog
Number T510001) purchased from Gene Therapy Systems,
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RNA interference process by using recombinant human
dicer enzyme to cleave in vitro-transcribed dsRNA into a
pool of 22-bp siRNAs (Fig. 1B). The total RNA of HKN/
2002 genome was prepared with Trizol reagent (GIBCO
BRL) according to the manufacturer’s instructions, and the
cDNAs of five targeted regions were obtained by reverse
transcription-PCR (RT-PCR) amplification with superscript
one-step RT-PCR system (GIBCO BRL) using the primers
as followed: for 5VNCR, 5V-GGAATTCATGTTTGC-
CCGTTTTCATGAG-3V (sense) and 5V-CGGGATCC
CCTCTAGACCTGGAAAGA-3V (antisense); for VP4, 5V-
CGGGATCC TTGTTCTGAGTGTTGGTTG-3V (sense)
and 5V-GGGGTACCTTGTTCTGAGTGTTGGTTG-3V
(antisense); for VPg, 5V-GGAATTCATGAAGCTCCCA-
CAGCAGGAG-3V (sense) and 5V-CGGGATCCTTC-




CAATTG-3V (sense) and 5V-CGGGATCCAAATAGGAA-
GCGGGAAAAA-3V (antisense). The cDNA sequences
were determined by sequencing. We further obtained the
in vitro RNA transcription template by adding T7 RNA
polymerase promoters to the cDNAs by standard PCR. The
gene-specific PCR primers containing T7 promoter
sequence (5V-GCGTAATACGACTCACTATAGGGAGA-
3V) were derived from the primers for RT-PCR described
above. Then the generation, recovery, and quantitation of
dsRNAs were performed with the Turboscript T7 Tran-
scription kit. Finally, the siRNAs generated by Recombi-
nant Dicer Enzyme were purified with RNA purification
column to remove salts, unincorporated nucleotides, and the
undigested dsRNA. The purified siRNAs were qualified
and stored to be used in subsequent transfection experi-
ments (Fig. 1C).
Construction of reporter plasmids
To analyze the silencing of the expression of exogenous
reporter gene, five reporter plasmids were constructed by
cloning the cDNAs of five target sequences of FMDV
genome into the SalI–BamHI sites of pEGFP-N1 (Clontech,
Palo Alto, CA) to form fusion green fluorescent proteins,
respectively (Fig. 2). The resultant plasmids were p5NCR-
EGFP, pVP4-EGFP, pVPg-EGFP, pPOL-EGFP, and
p3NCR-EGFP. The correct open reading frames confirmed
by sequencing retained the fluorescent properties of the
fusion protein.
Transient cellular transfection and analysis of the targeted
gene and EGFP expression in BHK-21 cells
Cell cultures were incubated at 37 8C with 5% CO2.
The day before transfection, cells were trypsinized, diluted
with fresh medium, and seeded into 96-well culture plates(approximately 0.5  105 cells/well). BHK-21 cells
(about 80% confluent) were transfected with Lipofect-
amine 2000 reagent (Invitrogen) by the manufacturer’s
protocol in the presence of 0.2 Ag recombinant reporter
plasmid and/or 0.1 Ag siRNA. After an additional 24 h of
incubation, cells were observed for the expression of green
fluorescent protein on an Olympus BH-2 microscope and
photographed using a Nikon E950 video camera at a
magnification of 40 with an exposure time of 1/8 s.
Cells were further subjected to fluorescence-activated cell
sorting.
For detection of the targeted gene expression in BHK-21
at 24 h after transfection, total RNA was extracted from
BHK-21 culture with Trizol reagent, incubated for 1 h at 37
8C with Dnase RQ1, and subjected to the real-time Q-RT-
PCR analysis. Briefly, the real-time Q-RT-PCR was
performed in a 96-well plate (BioRad, Hercules, CA) in a
20-Al reaction volume containing components of the SYBR
RT-PCR Kit (Perfect Real Time) (TaKaRa, Kyoto, JP). The
20-Al reaction mixture contained 10 Al SYBR master mix
(2), 0.4 Al of 0.2 AM forward primer, 0.4 Al of 0.2 AM
reverse primer, 2.0 Al of 1 Ag RNA sample, and 7.2 Al
of water. The RT-PCR thermocycling program consisted of
50 8C for 30 min, 95 8C for 10 s, followed by 40 cycles of
95 8C for 5 s and 60 8C for 20 s. The primers employed
were the same as the primers for RT-PCR described above.
To confirm the specific amplification, melt-curve analysis of
the RT-PCR products was performed according to the
manufacturer’s protocol. Fluorescence was measured fol-
lowing each cycle and displayed graphically by iCycler iQ
Real-Time PCR Detection System Software Version 3.0A
(BioRad, Hercules, CA). RT-PCR products were further
cloned into T-vector for sequencing.
Viral challenge assay in BHK-21 cell
Virus infectivity was determined by serial dilution of
sample on BHK-21 cells grown in 96-well plates and the
virus titer was calculated as a TCID50 by the Reed–Muench
method (Reed and Muench, 1938). A viral suspension
titrated at 105 to 107 TCID50 per 0.1 ml was used for viral
challenge. BHK-21 cells (about 80% confluent) grown in
96-well plates were transiently transfected with 0.1 Ag
siRNA per well. After 5 h of transfection, the transfection
complex was removed and cells were washed twice with
RPMI 1640 medium. The transfected cells in one well of the
96-well plates were then infected with 100 TCID50 of virus
per 0.1 ml. After 1 h of adsorption, the inoculum was
removed and the cells were washed twice with RPMI 1640
medium. The infection then proceeded in RPMI 1640
medium supplemented with 10% fetal bovine serum. For
detecting the therapeutic potential of siRNA, in another
parallel experiment, transfection was performed after 1 h of
infection with the virus. FMDV replication in BHK-21 cells
was evaluated by virus titer (TCID50) in supernatant taken at
the time indicated.
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